The Cholesterol Conspiracy: How Big Pharma’s $200 Billion Lie Is Killing You

Written by Sayer Ji on August 23, 2025. Posted in Current News

What if everything you’ve been told about cholesterol is not just wrong, but deliberately inverted? What if the very substance demonized by a trillion-dollar pharmaceutical empire is actually essential for your survival—and lowering it is slowly destroying your brain, immune system, and will to live?

For over five decades, we’ve been sold the greatest medical lie in human history. The cholesterol hypothesis—the idea that dietary cholesterol and blood cholesterol are the primary cause of heart disease—has generated over $200 billion in statin sales while systematically poisoning an entire generation.

Source: https://www.globalmarketstatistics.com/market-reports/cholesterol-lowering-drug-market-10539

But the real crime isn’t just the money. It’s the 350+ documented adverse health effects that occur when cholesterol drops too low—effects that have been hidden, minimized, and buried by an industry that profits from your sickness.

Today, we expose the truth they don’t want you to know: Low cholesterol and cholesterol medication lowering drug effects are killing more people than high cholesterol ever did.

Learn more about the 350+ adverse effects linked to statin drugs on the Greenmedinfo.com database: https://greenmedinfo.com/toxic-ingredient/statin-drugs

The evidence is overwhelming, and it’s been hiding in plain sight. Multiple large-scale studies spanning decades reveal a shocking truth: people with the lowest cholesterol levels die at dramatically higher rates than those with moderate levels.

First, let’s clarify an essential point. Cholesterol, as commonly described, is not what people think. It’s low-density lipoprotein, and as a protein, it carries fat-soluble compounds like cholesterol and other essential factors such as fat-soluble antioxidants, fatty acids, and vitamins through the plasma (the water-based portion of the blood). Otherwise, these vital compounds could not be transported throughout the body.

What’s often labeled “bad cholesterol” is, in reality, a vital transport system that sustains cellular function and survival. Importantly, non-oxidized LDL is qualitatively and functionally very different from oxidized cholesterol. The latter arises more readily when consuming rancid or heavily cooked fats, or when exposed to pro-oxidant compounds such as tobacco smoke, e-cigarette aerosols, toxic metals, and plastics.

It is this oxidized form known as ox-LDL —not healthy LDL itself—that poses a greater risk to vascular health, underscoring how lifestyle and environmental exposures, rather than cholesterol per se, are the real culprits in driving cardiovascular disease.

There’s also a growing awareness that saturated fats, even naturally occurring trans fatty acids in animal products like butter, may be essential and incredibly healthy. Learn more by reading my recent article on the topic below:

In a landmark analysis of 19,000 U.S. adults, researchers discovered that individuals with LDL cholesterol below 70 mg/dL had a 37% higher risk of death compared to those in the 100-129 mg/dL range—even after adjusting for other health factors.¹

But that’s just the beginning. A massive Korean study of 12.8 million adults found the lowest overall mortality among people with total cholesterol around 210-249 mg/dL. Those with cholesterol below 180-200 mg/dL? They died at significantly higher rates.² The increase in death risk at low cholesterol levels was actually more pronounced than the risk associated with high cholesterol.²

A Danish cohort confirmed this disturbing pattern, documenting a clear U-shaped curve where both extremely low and extremely high cholesterol increased mortality risk—with the sweet spot in the middle.³

The Elderly: Where the Lie Falls Apart

The cholesterol myth becomes most transparent in older populations. In study after study of adults over 65, those with the lowest cholesterol (LDL) consistently experience higher death rates, while higher cholesterol in late life becomes protective rather than harmful.⁴,⁵

The Cardiovascular Health Study and similar trials in seniors found that low total or LDL cholesterol predicted greater 5-year mortality, whereas moderate levels were relatively protective.⁴ Even among Chinese adults over 80, lower LDL predicted higher death rates—a complete inversion of everything we’ve been taught.⁶

The conclusion is inescapable: past a certain age, cholesterol becomes a marker of vitality, and chronically low levels signal underlying frailty or disease.

1. The Cancer Connection They’re Hiding

Here’s what the statin pushers don’t want you to know: low cholesterol has been consistently linked to higher rates of cancer and cancer death.

Multiple studies and reviews have documented that people with very low total cholesterol show increased cancer incidence and mortality.⁷,⁸ In some long-term cohorts, individuals in the lowest cholesterol brackets had significantly greater risk of cancer diagnosis in subsequent years.⁷

A 19-year follow-up of over 172,000 men and women found that low cholesterol was initially associated with more cancer cases, suggesting that low cholesterol can actually precede cancer onset.⁹

The pharmaceutical industry tries to dismiss this as “reverse causation”—claiming that undiagnosed cancers lower cholesterol, not the other way around. But this explanation conveniently ignores the mounting evidence that cholesterol plays a protective role against tumor formation and growth.

Bottom line: Several types of cancer have been directly associated with lower cholesterol levels—a fact that should terrify anyone taking aggressive cholesterol-lowering medications.⁷

Learn more by reading: Cracking the Cholesterol Myth: How Statins Harm The Body and Mind

2. Brain Destruction: The Cognitive Cost of Low Cholesterol

Your brain is the most cholesterol-rich organ in your body, containing about 25% of your total cholesterol (in dry weight form). So what happens when pharmaceutical companies convince you to drive those levels into the ground?

Cognitive decline, memory loss, and brain atrophy.

The Neuroscience is Clear

A groundbreaking 2020 study examined people with “desirable” cholesterol levels below 200 mg/dL and made a shocking discovery: those at the lower end (under 160 mg/dL) performed significantly worse on cognitive tests and showed measurable brain atrophy in the hippocampus—the brain’s memory center.¹³,¹⁴

The researchers found that semantic fluency (word recall) was reduced in low-cholesterol individuals, and brain scans confirmed lower gray matter volume in critical regions. Their conclusion was unambiguous: “Low-normal cholesterol level (i.e., <160 mg/dL) might have a detrimental effect on both cognition and brain health.”¹⁴

The Mental Health Epidemic

But the brain damage doesn’t stop at memory loss. The connection between low cholesterol and mental health problems is one of the most robust findings in all of medicine—and one of the most suppressed.

Depression: A landmark 1993 Lancet study found that men over 70 with low cholesterol were three times more likely to be diagnosed with major depression than those with higher levels.¹⁵ This has been replicated repeatedly: middle-aged men with long-term low cholesterol show significantly more depressive symptoms,¹⁵ and women in the lowest cholesterol decile experience much more depression and anxiety.¹⁶

A 2008 meta-analysis confirmed what individual studies had been showing for years: higher total cholesterol is associated with lower depression risk.¹⁷

Suicide: The most disturbing finding of all. In the massive MRFIT study of over 350,000 men, those with total cholesterol under 160 mg/dL had a significantly higher risk of suicide and violent death.²⁰

Study after study in psychiatric patients reveals the same pattern. Bipolar patients who attempted suicide had notably lower cholesterol levels than those who hadn’t.²¹ A comparison of 417 suicide attempters versus 155 non-attempting psychiatric patients found lower cholesterol as a significant distinguishing factor.²²

Even the method of suicide correlates with cholesterol levels: those choosing violent methods (firearms, hanging) had much lower total cholesterol than those who attempted nonviolent means.²³

One clinical analysis concluded that serum cholesterol could be used as an indicator of suicide risk, with danger thresholds around 180 mg/dL. Depressed patients who had attempted suicide averaged only ~150 mg/dL total cholesterol, versus ~180 mg/dL in non-suicidal depressed patients and ~190 mg/dL in healthy controls.²⁴

Violence: The connection extends beyond self-harm. A Swedish study tracking 80,000 adults found that those with lower cholesterol had significantly higher rates of violent crime and arrests.²⁵

Why This Happens

Cholesterol is essential for serotonin receptor function in the brain. When cholesterol drops too low, serotonin activity plummets, leading to depression, impulsivity, and violent behavior.¹⁸,¹⁹ This isn’t speculation—it’s documented neurochemistry that the pharmaceutical industry would prefer you never learn.

3. Hemorrhagic Stroke: When “Heart-Healthy” Becomes Brain-Deadly

While the medical establishment focuses obsessively on preventing clot-based strokes, they’ve conveniently ignored a deadly side effect of their cholesterol crusade: very low cholesterol dramatically increases the risk of brain hemorrhages.

The research is crystal clear: there’s an inverse relationship between total cholesterol and hemorrhagic stroke incidence.²⁷ The lower your cholesterol, the higher your risk of bleeding in the brain.

The Women’s Health Study Bombshell

The most damning evidence comes from a large prospective study of 27,000 women. Those with LDL cholesterol below 70 mg/dL had over twice the risk of hemorrhagic stroke compared to women with LDL in the 100-129 mg/dL range.²⁸

This represented a 2.17-fold increase in risk—statistically significant even after adjusting for blood pressure and other stroke factors.²⁸ Critically, the risk was not elevated for women with mildly low or moderately high LDL. It was specifically the ultra-low LDL group that saw the spike in brain hemorrhages.²⁸

The Mechanism

Other studies confirm that LDL levels below 60-70 mg/dL correlate with higher rates of intracerebral hemorrhage.²⁹,³⁰ The mechanism appears to be that extremely low cholesterol weakens blood vessel walls or impairs their repair, making them more susceptible to rupture.³¹

Clinical trials of intensive cholesterol-lowering have repeatedly noted more hemorrhagic strokes in aggressively treated patients—even as ischemic strokes decrease.³²,³³ This represents a deadly trade-off that patients are never informed about.

4. Immune System Collapse: How Low Cholesterol Leaves You Defenseless

Perhaps the most hidden danger of all: cholesterol is absolutely essential for immune function, and driving it too low leaves your body defenseless against infections and disease.

Cholesterol: Your Body’s Natural Antibiotic

LDL particles don’t just transport cholesterol—they actively bind and neutralize bacterial toxins, particularly endotoxins from dangerous gram-negative bacteria. They serve as a crucial first line of defense against infection.³⁴,³⁵

As one review stated: “Lipids are a key player in the battle between the host and microorganisms.”³⁴ When cholesterol is driven artificially low, this protective effect is eliminated.

The Clinical Evidence

Infection Rates: Observational studies consistently show that healthy individuals with low LDL levels suffer significantly higher rates of infectious disease than those with normal or high LDL.⁸ People at the bottom of the LDL range have markedly increased risk of hospitalizations for infections, pneumonias, and sepsis.⁸

Death from Infection: A 2018 study of patients with kidney disease found that higher LDL and HDL were associated with lower risk of death from infections, while patients with low lipids had the highest infection mortality.³⁷ Low LDL was linked to greater all-cause mortality primarily due to infections, not heart disease.³⁷

ICU Survival: A recent study of ICU patients revealed that those admitted with cholesterol in the lowest quintile had 46% higher odds of dying in the hospital than those in the highest quintile.³⁸ Many of these deaths were from sepsis and multi-organ failure—conditions where cholesterol helps mitigate inflammatory damage.³⁸

The “Lipid Paradox” in Critical Illness

During severe infection or trauma, cholesterol levels naturally plummet as part of the body’s acute-phase response. But persistently low levels predict worse outcomes and higher mortality.³⁹,⁴⁰ Cholesterol appears integral to surviving severe illness—it’s fuel and building material for immune cells.

Experimental studies confirm this: raising cholesterol in animals with infections improves outcomes, while lowering cholesterol worsens survival.⁴¹ This suggests that aggressive cholesterol-lowering may inadvertently undercut the body’s natural defenses.³⁴

The Goldilocks Zone They Don’t Want You to Find

The evidence is overwhelming: optimal cholesterol levels exist in a “Goldilocks zone”—not too high, but definitely not too low.

For decades, we’ve been told that “lower is better” when it comes to cholesterol. But the real-world data tells a different story:

• Higher overall mortality at very low levels¹
• More cancer in the lowest cholesterol groups⁷
• Increased hemorrhagic stroke risk below 70 mg/dL²⁸
• Cognitive decline and brain atrophy under 160 mg/dL¹⁴
• Depression, suicide, and violence at low levels¹⁵,²⁰,²⁵
• Impaired immune function and infection susceptibility⁸

The Industry’s Response: Denial and Deflection

When confronted with this evidence, the pharmaceutical industry employs predictable tactics:

1. Claim “reverse causation” – arguing that disease lowers cholesterol, not the other way around
2. Focus only on cardiovascular outcomes while ignoring all other causes of death
3. Cherry-pick studies that support their narrative while burying contradictory evidence
4. Attack the messenger rather than address the science

But the data is too consistent, too robust, and too widespread to dismiss. The correlations between low cholesterol and adverse outcomes appear across:

• Different populations and ethnicities
• Various study designs and time periods
• Multiple countries and healthcare systems
• Diverse age groups and health statuses

The Personalized Medicine Revolution

This doesn’t mean cholesterol-lowering drugs are universally harmful. In fact, one theory is they may help a subpopulation reduce inflammation in their arteries, which could have a slight benefit in the reduction of cardiovascular mortality, even if it increases mortality from infection, cancer, and cardiomyopathy. Context matters enormously:

• For a high-risk, middle-aged person with very high cholesterol, moderate reduction can be lifesaving
• For an elderly person, someone with depression, or anyone with a history of infections, pushing cholesterol to ultra-low ranges may do more harm than good
• Even within statin trials, patients who achieved moderate reductions got cardiac benefits, but those pushed to extremes sometimes saw no further gains in longevity or even increased non-cardiac deaths³,⁴²

The true goal should be extending healthspan and cultivating overall well-being—not merely chasing lower numbers on a lab report. In fact, there are a wide variety of natural agents shown to support healthy cholesterol balance, many of which demonstrate effectiveness and greater safety compared to the statin drug class. A number of these evidence-based alternatives are indexed in the: Cholesterol: High Database.

Breaking Free from the Cholesterol Conspiracy

For over 50 years, a powerful medical-industrial complex has convinced us that cholesterol is the enemy. They’ve created a trillion-dollar industry based on the false premise that driving cholesterol as low as possible will save us from heart disease.

But the human body is not that simple. Cholesterol serves essential roles in every cell, every organ system, and every aspect of human health. When we artificially suppress this vital molecule, we create new diseases while claiming to prevent old ones.

The evidence for the dangers of low cholesterol is hiding in plain sight—in peer-reviewed journals, major medical databases, and large-scale population studies. The only reason you haven’t heard about it is because there’s no money in telling you that your body might actually know what it’s doing.

It’s time to reclaim the truth about cholesterol. Your life—and your sanity—may depend on it.

References

1. Association between low density lipoprotein cholesterol and all-cause mortality: results from the NHANES 1999-2014. Scientific Reports, 2021.
2. Total cholesterol and all-cause mortality by sex and age: a prospective cohort study among 12.8 million adults. Scientific Reports, 2018.
3. Association between low density lipoprotein and all cause and cause specific mortality in Denmark: Prospective cohort study. ResearchGate, 2020.

4-6. Association between low density lipoprotein cholesterol and all-cause mortality: results from the NHANES 1999-2014. Scientific Reports, 2021.

7-8. Total cholesterol and all-cause mortality by sex and age: a prospective cohort study among 12.8 million adults. Scientific Reports, 2018.

9-11. Association between low density lipoprotein cholesterol and all-cause mortality: results from the NHANES 1999-2014. Scientific Reports, 2021.

12-26. The Implications Of Low Cholesterol In Depression And Suicide. MosaicDX, 2023.

13-14. Low-Normal Cholesterol Levels Are Associated With Lower Cognitive Function. Frontiers in Aging Neuroscience, 2020.

27. Cholesterol Levels and Risk of Hemorrhagic Stroke. Stroke, 2013.
28. Lipid levels and the risk of hemorrhagic stroke among women. PubMed, 2019.
29. Low Cholesterol Linked to Higher Risk of Bleeding Stroke in Women. American Academy of Neurology, 2019.

30-33. Multiple studies from Stroke journal and Arteriosclerosis, Thrombosis, and Vascular Biology, 2014-2022.

34-41. Association between low density lipoprotein cholesterol and all-cause mortality: results from the NHANES 1999-2014. Scientific Reports, 2021.

37-38. Association between lipid levels and all-cause and cause-specific mortality in critically ill patients. Scientific Reports, 2023.

39. Effect of Inflammation and Infection on Lipids and Lipoproteins. NCBI Bookshelf, 2018.
40. Lipid levels are inversely associated with infectious and all-cause mortality. Journal of Lipid Research, 2018.
41. Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia. Arteriosclerosis, Thrombosis, and Vascular Biology, 2014.

source  sayerji.substack.com

Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.